Vaughn Himes - Mar 2, 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Signature
By: /s/ Jennifer Prosba For: Vaughn B Himes
Stock symbol
SGEN
Transactions as of
Mar 2, 2023
Transactions value $
-$2,208,014
Form type
4
Date filed
3/3/2023, 04:36 PM
Previous filing
Sep 1, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $555K +13.5K +20.11% $41.04 80.8K Mar 2, 2023 Direct F1
transaction SGEN Common Stock Sale -$2.39M -13.5K -16.74% $177.07 67.3K Mar 2, 2023 Direct F1, F2, F3
transaction SGEN Common Stock Options Exercise $110K +2.69K +4% $41.04 69.9K Mar 2, 2023 Direct F1
transaction SGEN Common Stock Sale -$479K -2.69K -3.85% $177.92 67.3K Mar 2, 2023 Direct F1, F2, F4
holding SGEN Common Stock 119K Mar 2, 2023 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -13.5K -41.7% $0.00 18.9K Mar 2, 2023 Common Stock 13.5K $41.04 Direct F5
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.69K -14.23% $0.00 16.2K Mar 2, 2023 Common Stock 2.69K $41.04 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 74 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2023.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $176.58 to $177.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $177.60 to $178.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Options vested at a rate of 25% on 8/19/14 and monthly thereafter until all the options were fully vested on 8/19/17.